ESAB Corp·4

May 12, 4:47 PM ET

Jordan Rhonda L 4

4 · ESAB Corp · Filed May 12, 2026

Research Summary

AI-generated summary of this filing

Updated

ESAB Director Rhonda L. Jordan Receives 3,460-Share Award

What Happened Rhonda L. Jordan, a director of ESAB Corp (ESAB), was granted awards on 2026-05-08 totaling 3,460 derivative units: 2,647 stock options that vested and became exercisable on the grant date, and 813 deferred stock units (DSUs). Both grants were reported at an acquisition price of $0.00 (awards), so there was no cash purchase; the awards have potential future value tied to ESAB common stock price if/when converted or exercised.

Key Details

  • Transaction date: May 8, 2026; Form 4 filed May 12, 2026 (timely filing).
  • Grants: 2,647 stock options (vested and exercisable on grant date); 813 deferred stock units — total = 3,460 derivative units.
  • Reported price: $0.00 for each grant (award/grant, not an open-market purchase).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnotes from the filing:
    • F1: The 2,647 stock options vested and became exercisable on the grant date.
    • F2: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
    • F3: The 813 DSUs vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after the director’s separation from the company.

Context

  • The 2,647 options are now exercisable but were not reported as exercised or sold — they are a derivative award, not an immediate purchase or sale.
  • The 813 DSUs are deferred compensation: they do not convert to shares until vesting and are payable in stock only after separation, so they represent a future contingent payout rather than current ownership.
  • Awards at $0.00 are routine compensation for directors and should be viewed as grants of potential future value rather than an immediate market purchase.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-08+2,6472,647 total
    Exercise: $100.94From: 2026-05-08Exp: 2033-05-07Common stock, par value $0.001 (2,647 underlying)
  • Award

    Deferred Stock Units

    [F2][F3]
    2026-05-08+813813 total
    Common stock, par value $0.001 (813 underlying)
Footnotes (3)
  • [F1]These stock options vested and became exercisable on the grant date.
  • [F2]Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
  • [F3]These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.
Signature
/s/ Curtis E. Jewell, Attorney-in-Fact|2026-05-12

Documents

1 file
  • 4
    wk-form4_1778618819.xmlPrimary

    FORM 4